• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过运动试验评估曲美他嗪的急性效应。

Acute effects of trimetazidine evaluated by exercise testing.

作者信息

Sellier P, Audouin P, Payen B, Corona P, Duong T C, Ourbak P

机构信息

Department of Cardiology, Hôpital Broussais, Paris, France.

出版信息

Eur J Clin Pharmacol. 1987;33(2):205-7. doi: 10.1007/BF00544569.

DOI:10.1007/BF00544569
PMID:3691610
Abstract

A single dose of 60 mg trimetazidine (the normal daily dose) improved exercise capacity in angina pectoris, as reflected by an increase in the duration of exercise, total work performed, and improvement in ECG signs of ischaemia. All these effects occurred without any detectable chronotropic or vasomotor effect. The importance of this study is to demonstrate that these beneficial effects, already well-recognized after chronic administration of 20 mg three times a day, also occur after a single administration equivalent to the normal daily dose.

摘要

单剂量60毫克曲美他嗪(正常日剂量)可改善心绞痛患者的运动能力,表现为运动持续时间增加、总做功量提高以及缺血性心电图体征改善。所有这些效应出现时均未检测到任何变时性或血管舒缩效应。本研究的重要意义在于证明,这些在每日三次服用20毫克进行长期给药后已得到充分认可的有益效应,在单次给予相当于正常日剂量的药物后同样会出现。

相似文献

1
Acute effects of trimetazidine evaluated by exercise testing.通过运动试验评估曲美他嗪的急性效应。
Eur J Clin Pharmacol. 1987;33(2):205-7. doi: 10.1007/BF00544569.
2
[The effects of trimetazidine on ergometric parameters in exercise-induced angina. Controlled multicenter double blind versus placebo study].
Arch Mal Coeur Vaiss. 1986 Aug;79(9):1331-6.
3
[Clinical effectiveness of trimetazidine in stable effort angina. A double-blind versus placebo controlled study].[曲美他嗪治疗稳定型劳力性心绞痛的临床疗效。一项双盲与安慰剂对照研究]
Presse Med. 1986 Oct 16;15(35):1779-82.
4
Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.评估曲美他嗪缓释片35mg在稳定型心绞痛患者谷浓度时的抗缺血和抗心绞痛作用及安全性:一项多中心、双盲、安慰剂对照研究。
Am J Cardiovasc Drugs. 2003;3(5):361-9. doi: 10.2165/00129784-200303050-00007.
5
Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.曲美他嗪对稳定型心绞痛患者的抗心绞痛作用及左心室功能改善情况
Am J Cardiovasc Drugs. 2002;2(2):119-24. doi: 10.2165/00129784-200202020-00005.
6
Trimetazidine and stable angina a double-blind trial.曲美他嗪与稳定型心绞痛:一项双盲试验
J Med Assoc Thai. 1990 Mar;73(3):162-7.
7
Combination treatment with trimetazidine and diltiazem in stable angina pectoris.曲美他嗪与地尔硫䓬联合治疗稳定型心绞痛。
Heart. 1997 Oct;78(4):353-7. doi: 10.1136/hrt.78.4.353.
8
Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.曲美他嗪。关于其在稳定型心绞痛及其他冠状动脉疾病中应用的综述。
Drugs. 1999 Jul;58(1):143-57. doi: 10.2165/00003495-199958010-00016.
9
[Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)].曲美他嗪治疗稳定型心绞痛TRIADA研究(曲美他嗪治疗稳定型心绞痛每日两次)
Vnitr Lek. 2006 Jun;52(6):609-14.
10
[Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study].[曲美他嗪治疗慢性冠状动脉供血不足所致稳定型劳力性心绞痛的有效性:一项双盲对照安慰剂研究]
Presse Med. 1986 Oct 16;15(35):1775-8.

引用本文的文献

1
The imPAct of Trimetazidine on MicrOcirculation after Stenting for stable coronary artery disease (PATMOS study).曲美他嗪对稳定型冠状动脉疾病支架置入术后微循环的影响(PATMOS研究)
Front Cardiovasc Med. 2023 Jun 30;10:1112198. doi: 10.3389/fcvm.2023.1112198. eCollection 2023.
2
Trimetazidine and Other Metabolic Modifiers.曲美他嗪及其他代谢调节剂
Eur Cardiol. 2018 Dec;13(2):104-111. doi: 10.15420/ecr.2018.15.2.
3
Trimetazidine for prevention of induced ischemia and reperfusion of guinea pig retina.曲美他嗪预防豚鼠视网膜诱导性缺血和再灌注

本文引用的文献

1
Vasoactivity of trimetazidine on guinea-pig isolated ductus arteriosus.曲美他嗪对豚鼠离体动脉导管的血管活性作用。
Br J Pharmacol. 1985 Feb;84(2):517-24. doi: 10.1111/j.1476-5381.1985.tb12936.x.
2
[Research on the hemodynamic effects of trimetazidine, in a single administration in man].[曲美他嗪单次给药对人体血流动力学影响的研究]
Therapie. 1987 Mar-Apr;42(2):245-6.
3
[The effects of trimetazidine on ergometric parameters in exercise-induced angina. Controlled multicenter double blind versus placebo study].
Clin Ophthalmol. 2010 Feb 2;4:21-6. doi: 10.2147/opth.s8409.
4
Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis.脂肪酸氧化抑制剂在动脉粥样硬化慢性并发症管理中的应用
Curr Atheroscler Rep. 2005 Feb;7(1):63-70. doi: 10.1007/s11883-005-0077-2.
5
Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.曲美他嗪。关于其在稳定型心绞痛及其他冠状动脉疾病中应用的综述。
Drugs. 1999 Jul;58(1):143-57. doi: 10.2165/00003495-199958010-00016.
6
Acute oral trimetazidine administration increases resting technetium 99m sestamibi uptake in hibernating myocardium.急性口服曲美他嗪可增加冬眠心肌中静息状态下锝99m甲氧基异丁基异腈的摄取。
J Nucl Cardiol. 1998 Mar-Apr;5(2):128-33. doi: 10.1016/s1071-3581(98)90195-7.
7
Combination treatment with trimetazidine and diltiazem in stable angina pectoris.曲美他嗪与地尔硫䓬联合治疗稳定型心绞痛。
Heart. 1997 Oct;78(4):353-7. doi: 10.1136/hrt.78.4.353.
8
Trimetazidine increases phospholipid turnover in ventricular myocyte.曲美他嗪可增加心室肌细胞中的磷脂周转。
Mol Cell Biochem. 1997 Oct;175(1-2):153-62. doi: 10.1023/a:1006813403448.
9
Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.曲美他嗪:心绞痛治疗的新概念。与普萘洛尔治疗稳定型心绞痛患者的比较。曲美他嗪欧洲多中心研究组
Br J Clin Pharmacol. 1994 Mar;37(3):279-88. doi: 10.1111/j.1365-2125.1994.tb04276.x.
10
Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy.曲美他嗪对重度缺血性心肌病的心脏保护作用。
Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 4:861-5. doi: 10.1007/BF00051293.
Arch Mal Coeur Vaiss. 1986 Aug;79(9):1331-6.
4
Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells.曲美他嗪对人红细胞中氧自由基诱导的膜损伤的影响。
Br J Clin Pharmacol. 1985 Aug;20(2):148-51. doi: 10.1111/j.1365-2125.1985.tb05047.x.